Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03073252 · ClinicalTrials.gov registry record · NA
The Acute Effect of Egg-Based High Protein Meal on Hypertensive Response to Exercise
A NA study, sponsored by Purdue University.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT03073252 is a NA study that has completed, run by Purdue University. The registered enrollment target is 31 participants.
The verdict
NCT03073252, a NA study, has completed, sponsored by Purdue University.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The primary purpose of this study is to explore the effect of high versus normal egg-based protein meals on acute exercise-induced elevated blood pressure.
Interventions
- OTHER Normal Protein
- OTHER HIgh Protein
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2017-01-01 |
| Est. Completion | 2017-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03073252
The ClinicalTrials.gov registry entry for NCT03073252 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Purdue University, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Normal Protein is the first listed.
NCT03073252 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03073252 about?
NCT03073252 is a clinical study titled "The Acute Effect of Egg-Based High Protein Meal on Hypertensive Response to Exercise". The primary purpose of this study is to explore the effect of high versus normal egg-based protein meals on acute exercise-induced elevated blood pressure.
What is the current status of trial NCT03073252?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2017-01-01. Estimated completion is 2017-06-30.
What interventions are being tested in trial NCT03073252?
The interventions under investigation include: Normal Protein (OTHER), HIgh Protein (OTHER).
Who is sponsoring clinical trial NCT03073252?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.